Literature DB >> 27344223

Genetic Modifiers of Patent Ductus Arteriosus in Term Infants.

Priti M Patel1, Allison M Momany2, Kendra L Schaa3, Paul A Romitti4, Charlotte Druschel5,6, Margaret E Cooper7, Mary L Marazita7,8, Jeffrey C Murray2, John M Dagle2.   

Abstract

OBJECTIVE: To identify single-nucleotide polymorphisms (SNPs) in specific candidate genes associated with patent ductus arteriosus in term infants. STUDY
DESIGN: We conducted an initial family-based, candidate gene study to analyze genotype data from DNA samples obtained from 171 term infants and their parents enrolled in the National Birth Defects Prevention Study (NBDPS). We performed transmission disequilibrium testing (TDT) using a panel of 55 SNPs in 17 genes. Replication of SNPs with P < .1 in the NBDPS trios was performed with a case-control strategy in an independent population.
RESULTS: TDT analysis of the NBDPS trios resulted in 6 SNPs reaching the predetermined cutoff (P < .1) to be included in the replication study. These 6 SNPs were genotyped in the independent case-control population. A SNP in TGFBR2 was found to be associated with term patent ductus arteriosus in both populations after we corrected for multiple comparisons. (rs934328, TDT P = 2 × 10(-4), case-control P = 6.6 × 10(-5)).
CONCLUSIONS: These findings confirm the importance of the transforming growth factor-beta pathway in the closure of the term ductus arteriosus and may suggest new therapeutic targets. Published by Elsevier Inc.

Entities:  

Keywords:  CREBB; TGFBR2; TRAF1; candidate gene

Mesh:

Year:  2016        PMID: 27344223      PMCID: PMC5003735          DOI: 10.1016/j.jpeds.2016.05.066

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  20 in total

1.  The genetics of congenital heart disease: a point in the revolution.

Authors:  D Woodrow Benson
Journal:  Cardiol Clin       Date:  2002-08       Impact factor: 2.213

2.  Factors in the causation of persistent ductus arteriosus.

Authors:  P E POLANI; M CAMPBELL
Journal:  Ann Hum Genet       Date:  1960-12       Impact factor: 1.670

3.  Genetic and non-genetic factors in the etiology of congenital heart disease: a study of 1188 cases.

Authors:  M LAMY; J DE GROUCHY; O SCHWEISGUTH
Journal:  Am J Hum Genet       Date:  1957-03       Impact factor: 11.025

4.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.

Authors:  Bart L Loeys; Junji Chen; Enid R Neptune; Daniel P Judge; Megan Podowski; Tammy Holm; Jennifer Meyers; Carmen C Leitch; Nicholas Katsanis; Neda Sharifi; F Lauren Xu; Loretha A Myers; Philip J Spevak; Duke E Cameron; Julie De Backer; Jan Hellemans; Yan Chen; Elaine C Davis; Catherine L Webb; Wolfram Kress; Paul Coucke; Daniel B Rifkin; Anne M De Paepe; Harry C Dietz
Journal:  Nat Genet       Date:  2005-01-30       Impact factor: 38.330

Review 5.  The TDT and other family-based tests for linkage disequilibrium and association.

Authors:  R S Spielman; W J Ewens
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

6.  Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.

Authors:  Nahid Waleh; Ryan Hodnick; Nami Jhaveri; Suzanne McConaghy; John Dagle; Steven Seidner; Donald McCurnin; Jeffrey C Murray; Robin Ohls; Ronald I Clyman
Journal:  Pediatr Res       Date:  2010-10       Impact factor: 3.756

7.  Response of the patent ductus arteriosus to indomethacin treatment.

Authors:  J M Ramsay; D J Murphy; G W Vick; J T Courtney; J A Garcia-Prats; J C Huhta
Journal:  Am J Dis Child       Date:  1987-03

8.  Integration of DNA sample collection into a multi-site birth defects case-control study.

Authors:  Sonja A Rasmussen; Edward J Lammer; Gary M Shaw; Richard H Finnell; Robert E McGehee; Margaret Gallagher; Paul A Romitti; Jeffrey C Murray
Journal:  Teratology       Date:  2002-10

9.  Determination of genetic predisposition to patent ductus arteriosus in preterm infants.

Authors:  John M Dagle; Nathan T Lepp; Margaret E Cooper; Kendra L Schaa; Keegan J P Kelsey; Kristin L Orr; Diana Caprau; Cara R Zimmerman; Katherine M Steffen; Karen J Johnson; Mary L Marazita; Jeffrey C Murray
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

10.  Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates.

Authors:  Andras Treszl; Miklos Szabo; Gyorgy Dunai; Andras Nobilis; Istvan Kocsis; Tamas Machay; Tivadar Tulassay; Barna Vasarhelyi
Journal:  Pediatr Res       Date:  2003-08-06       Impact factor: 3.756

View more
  3 in total

1.  Genetic variants associated with patent ductus arteriosus in extremely preterm infants.

Authors:  John M Dagle; Kelli K Ryckman; Cassandra N Spracklen; Allison M Momany; C Michael Cotten; Joshua Levy; Grier P Page; Edward F Bell; Waldemar A Carlo; Seetha Shankaran; Ronald N Goldberg; Richard A Ehrenkranz; Jon E Tyson; Barbara J Stoll; Jeffrey C Murray
Journal:  J Perinatol       Date:  2018-12-05       Impact factor: 2.521

Review 2.  Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.

Authors:  Elaine L Shelton; Gautam K Singh; Colin G Nichols
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

3.  Next Generation Sequencing Identify Rare Copy Number Variants in Non-syndromic Patent Ductus Arteriosus.

Authors:  Bo Chen; Aiping Hou; Lin Zhao; Ying Liu; Xin Shi; Bowen Du; Yu Yu; Pengjun Zhao; Ying Gao
Journal:  Front Genet       Date:  2020-11-12       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.